Study | Exclusion reasons | Remarks | Reference(s) | ||
---|---|---|---|---|---|
BREATH-19 Study, 0 | single-arm | ||||
Gritti et al., 2020 | single-arm | inadequate or absent control group | |||
Huijie Bian, 2020 | non randomized controlled trial | not relevant study design | study with major methological limitations precluding any conclusion | ||
Yin Wang et al., 2020 | retrospective cohort (registry) | not relevant study design | |||
Roschewski, 2020 | observational study | no control group |
Roschewski M Sci Immunol 2020 Jun 5;5(48):eabd0110. 10.1126/sciimmunol.abd0110 |
||
Bargay-Lleonart, 2022 | randomized controlled trial | no clinically relevant endpoint | The trial was terminated early due to the impossibility of recruitment due to the pandemic. |
Bargay-Lleonart J J Clin Med 2022 May 27;11(11):3039. 10.3390/jcm11113039 |
|
Dai W, 2020 | retrospective cohort | other | inadequate statistical analysis |
Wei Dai, Jian Wu, Tianfu Li, Jiawei Shen, Rongrong Pang, Bangshun He, Tao Luo, Yanju Guo, Yang Yang, Jun Zhao, Mingchao Zhang, Na Li, Ying Han, Qiuyue Wu, Weiwei Li, Xinyi Xia BMC Cardiovascular Diabetology |
|
Bernaola, 2020 | retrospective cohort | other |
Nikolas Bernaola medrxiv;2020.07.17.20155960v1 10.1101/2020.07.17.20155960 |
||
Holt, 2020 | retrospective cohort | other | no CI reported | ||
Klopfenstein, 2020 | retrospective cohort | other | major flaws in the method |
Klopfenstein T International Journal of Infectious Diseases 10.1016/j.ijid.2020.08.024 |
|
Cantini, 2020 | non randomized controlled trial | other | same patients than in Cantini et al. (octobre publication) |
Cantini F J Infect 2020 Aug;81(2):318-356. 10.1016/j.jinf.2020.04.017 |